Portfolio Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-150
Closed -$16K 127
2018
Q3
$16K Hold
150
0.01% 127
2018
Q2
$13K Hold
150
0.01% 139
2018
Q1
$12K Sell
150
-100
-40% -$8.05K 0.01% 148
2017
Q4
$21K Buy
+250
New +$21.3K 0.01% 124

Other funds holding LLY

Portfolio Strategies's LLY Position: Q4 2018 in Review

Portfolio Strategies sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 150 shares — an estimated $16K sold.

Portfolio Strategies first reported a position in LLY in Q4 2017 and held it in 4 quarters. The position peaked at $21K in Q4 2017. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Portfolio Strategies reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • Portfolio Strategies sold 150 Eli Lilly shares in Q4 2018, an estimated $16K.
  • Portfolio Strategies first reported a position in Eli Lilly in Q4 2017 and held it in 4 quarters.
  • Portfolio Strategies's Eli Lilly position peaked at $21K in Q4 2017.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Portfolio Strategies's 13F filing for Q4 2018, filed 4 Feb 2019.